An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor
Sponsor: Medtronic Diabetes
Listed as NCT01112696, this NA trial focuses on Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus and remains completed. Sponsored by Medtronic Diabetes, it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Dec 2017 — Jun 2018 [monthly]
Completed NA
Phase: PHASE3 → NA
-
Jan 2017 — Dec 2017 [monthly]
Completed PHASE3
First recorded
Apr 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Diabetes
For direct contact, visit the study record on ClinicalTrials.gov .